Effects of Evolocumab on the ApoA1 Remnant Ratio: A Pooled Analysis of Phase 3 Studies

INTRODUCTION: The apolipoprotein A1 (apoA1) remnant ratio has been identified as an independent cardiovascular (CV) risk factor. Higher apoA1 remnant ratios may predict lower CV risk in some patients. This analysis aimed to evaluate the effects of evolocumab on the change from baseline in the apoA1...

Fuld beskrivelse

Na minha lista:
Bibliografiske detaljer
Udgivet i:Cardiol Ther
Main Authors: May, Heidi T., Muhlestein, Joseph B., Ma, Yuhui, López, J. Antonio G., Coll, Blai, Nelson, John
Format: Artigo
Sprog:Inglês
Udgivet: Springer Healthcare 2019
Fag:
Original Research
Online adgang:https://ncbi.nlm.nih.gov/pmc/articles/PMC6525215/
https://ncbi.nlm.nih.gov/pubmed/30852766
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s40119-019-0133-6
Tags: Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!

Lignende værker